- Home
- ARQQ vs LVTX Comparison
ARQQ vs LVTX Comparison
Compare ARQQ & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQQ
- LVTX
- Stock Information
- Founded
- ARQQ 2017
- LVTX 2016
- Country
- ARQQ United Kingdom
- LVTX Netherlands
- Employees
- ARQQ N/A
- LVTX N/A
- Industry
- ARQQ Computer Software: Prepackaged Software
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- ARQQ Technology
- LVTX Health Care
- Exchange
- ARQQ Nasdaq
- LVTX Nasdaq
- Market Cap
- ARQQ 50.0M
- LVTX 43.9M
- IPO Year
- ARQQ N/A
- LVTX 2021
- Fundamental
- Price
- ARQQ $3.79
- LVTX $1.69
- Analyst Decision
- ARQQ Strong Buy
- LVTX Strong Buy
- Analyst Count
- ARQQ 1
- LVTX 2
- Target Price
- ARQQ $50.00
- LVTX $6.00
- AVG Volume (30 Days)
- ARQQ 107.1K
- LVTX 34.6K
- Earning Date
- ARQQ 11-19-2024
- LVTX 11-14-2024
- Dividend Yield
- ARQQ N/A
- LVTX N/A
- EPS Growth
- ARQQ N/A
- LVTX N/A
- EPS
- ARQQ N/A
- LVTX N/A
- Revenue
- ARQQ $740,000.00
- LVTX $7,398,000.00
- Revenue This Year
- ARQQ $341.56
- LVTX N/A
- Revenue Next Year
- ARQQ $274.91
- LVTX N/A
- P/E Ratio
- ARQQ N/A
- LVTX N/A
- Revenue Growth
- ARQQ N/A
- LVTX N/A
- 52 Week Low
- ARQQ $3.72
- LVTX $1.13
- 52 Week High
- ARQQ $23.00
- LVTX $6.47
- Technical
- Relative Strength Index (RSI)
- ARQQ 31.90
- LVTX 48.19
- Support Level
- ARQQ $4.35
- LVTX $1.58
- Resistance Level
- ARQQ $6.00
- LVTX $1.75
- Average True Range (ATR)
- ARQQ 0.83
- LVTX 0.09
- MACD
- ARQQ -0.15
- LVTX 0.01
- Stochastic Oscillator
- ARQQ 1.65
- LVTX 61.11
About ARQQ Arqit Quantum Inc.
Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology which makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. Arqit delivers its symmetric key agreement technology via its QuantumCloud. Its product, QuantumCloud, enables any device to download a lightweight software agent, which can create keys in partnership with any other device. The firm operates in one segment that is, the provision of cybersecurity services via satellite and terrestrial platforms. Key revenue comes from the UK.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer.